Erratum zu: Kosteneffektivität von GnRH-Antagonisten bei Patienten mit Prostatakarzinom und kardiovaskulärem Risiko. Vergleichende Analyse gegenüber Leuprorelin anhand der Number Needed to TreatErratum to: Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk. Comparative analysis with leuprolide on the basis of the Number Needed to Treat

被引：0
|
作者：
D. Anderson
J. Lehmann
T. Ecker
S. Vosgerau
V. Donatz
机构：
[1] Ecker + Ecker GmbH,Klinik für Urologie
[2] Städtisches Krankenhaus,undefined
[3] Ferring Arzneimittel GmbH,undefined
来源：
Der Urologe | 2017年 / 56卷 / 7期
关键词：
D O I：
10.1007/s00120-017-0426-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：924 / 924
相关论文
共 2 条
  • [1] Cost Effectiveness of GnRH Antagonists in Patients with Prostate Cancer and cardiovascular Risk Comparative Analysis against Leuprorelin by the Number Needed to Treat
    Anderson, D.
    Lehmann, J.
    Ecker, T.
    Vosgerau, S.
    Donatz, V.
    UROLOGE, 2017, 56 (07): : 917 - 924
  • [2] Cost effectiveness of GnRH antagonists in patients with prostate cancer and cardiovascular risk. Comparative analysis with leuprolide on the basis of the Number Needed to Treat (vol 56, pg 917, 2017)
    Anderson, D.
    Lehmann, J.
    Ecker, T.
    Vosgerau, S.
    Donatz, V.
    UROLOGE, 2017, 56 (07): : 924 - 924
1